help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 20, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0361
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/1/147    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ceraudo, E.
Right arrow Articles by Laburthe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ceraudo, E.
Right arrow Articles by Laburthe, M.

Submitted on July 23, 2007
Accepted on September 13, 2007

The vasoactive intestinal peptide alpha helix up to C-terminus interacts with the N-terminal ectodomain of the human VPAC1 receptor : photoaffinity, molecular modeling and dynamics

Emilie Ceraudo, Samuel Murail, Yossan-Var Tan, Jean-Jacques Lacapère, Jean-Michel Neumann, Alain Couvineau, and Marc Laburthe*

INSERM U773, Institut National de la Santé et de la Recherche Médicale, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3, Faculté de Médecine Xavier Bichat, 75018 Paris, France; and CEA DSV/DBJC, URA CNRS 2096, Centre d'Etudes de Saclay, 91191 Gif sur Yvette Cedex, France

* To whom correspondence should be addressed. E-mail: laburthe{at}bichat.inserm.fr.

The neuropeptide vasoactive intestinal peptide (VIP) strongly impacts on human pathophysiology and does so through interaction with class II G protein-coupled receptors. We characterized the C-terminus binding site of VIP in the N-terminal ectodomain (N-ted) of the human VPAC1 receptor: (i) The probe 125I-[Bpa28]-VIP in which the C-terminal residue (Asn28) is substituted by a photoreactive para-benzoyl-L-Phe (Bpa) was used to photolabel the receptor. After receptor cleavage and Edman sequencing, it was shown that Asn28 of VIP is in contact with Lys127 in the receptor N-ted. Taking into account previous data, it follows that the C-terminal and central parts of VIP from Asn28 to Phe6 lie in the N-ted. (ii) A 3D model of the N-ted was constructed, the fold being identified as a Sushi domain with two antiparallel {beta} sheets and three disulfide bonds. The NMR structure of VIP was then docked into this model by taking into account the constraint provided by photoaffinity experiments with 125I-[Bpa28]-VIP. It appeared that VIP runs parallel to the {beta}3-{beta}4 antiparallel sheets. (iii) We performed molecular dynamic simulations over 14 ns of the complex between VIP and receptor N-ted and the free N-ted. The structural model of the free N-ted is stable and VIP tends to further stabilize the N-ted structure more especially in the loops connecting the {beta} sheets. These structural studies provide a detailed molecular understanding of the VIP-receptor interaction.


Key words: VIP • PACAP • VPAC1 receptor • GPCR • ectodomain







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society